Detailed DARPP-32 expression profiles in postmortem brains from patients with schizophrenia: An immunohistochemical study

Medical Molecular Morphology

Volumn 44, Issue 4, 2011, Pages 190-199

  Kunii, Yasuto ^a   Ikemoto, Keiko ^a   Wada, Akira ^a   Yang, Qiaohui ^a   Kusakabe, Takashi ^a   Suzuki, Toshimitsu ^a   Niwa, Shin Ichi ^a  

^a FUKUSHIMA MEDICAL UNIVERSITY   (Japan)

Author keywords

Astrocyte; DARPP 32; Immunohistochemistry; Neuron; Postmortem brains; Schizophrenia

Indexed keywords

ANTIBODY; CELL MARKER; CHLORPROMAZINE; PHOSPHOPROTEIN DARPP 32; PROMETHAZINE; THREONINE;

ADULT; AGED; ARTICLE; AUTOPSY; BRAIN; BRAIN REGION; CELL DENSITY; CLINICAL ARTICLE; CONTROLLED STUDY; FEMALE; HUMAN; HUMAN CELL; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; MALE; NERVE CELL; PHOSPHORYLATION; PREFRONTAL CORTEX; PRIORITY JOURNAL; PROTEIN EXPRESSION; SCHIZOPHRENIA;

ADULT; AGED; AGED, 80 AND OVER; BIOLOGICAL MARKERS; BRAIN; CASE-CONTROL STUDIES; CELLS, CULTURED; DOPAMINE AND CAMP-REGULATED PHOSPHOPROTEIN 32; FEMALE; GENE EXPRESSION; GLIAL FIBRILLARY ACIDIC PROTEIN; HUMANS; MALE; MIDDLE AGED; PHOSPHORYLATION; PREFRONTAL CORTEX; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; SCHIZOPHRENIA;

EID: 84862908578     PISSN: 18601480     EISSN: 18601499     Source Type: Journal    
DOI: 10.1007/s00795-010-0524-1     Document Type: Article

References (35)

1. Del Arco A, Mora F (2008) Prefrontal cortex-nucleus accumbens interaction: in vivo modulation by dopamine and glutamate in the prefrontal cortex. Pharmacol Biochem Behav 90:226-235
2. Berger B, Febvret A, Greengard P, Goldman-Rakic PS (1990) DARPP-32, a phosphoprotein enriched in dopaminoceptive neurons bearing D1 receptors: distribution in the cerebral cortex of newborn and adult rhesus monkey. J Comp Neurol 229:327-348 (Pubitemid 20319171)
3. Brene S, Hall H, Lindefors N, Karlson P, Halldin C, Sedvall G (1995) Distribution of messenger RNAs for D1 dopamine receptors and DARPP-32 in striatum and cerebral cortex of the cynomolgus monkey: relationship to D1 dopamine receptors. Neuroscience 67:37-48
4. Ouimet C, Miller PE, Hemmings HC Jr, Walaas SI, Greengard P (1984) DARPP-32, a dopamine-and adenosine 3′:5′-monophosphate-regulated phosphoprotein enriched in dopamine-innervated brain regions. III: Immunocytochemical localization. J Neurosci 4:111-124 (Pubitemid 14198292)
5. Ouimet C, Lamantia AS, Goldman-Rakic P, Rakic P, Greengard P (1992) Immunocytochemical localization of DARPP-32, a dopamine and cyclic AMP-regulated phosphoprotein, in the primate brain. J Comp Neurol 323:209-218
6. Walaas SI, Greengard P (1984) DARPP-32, a dopamine-and adenosine 3':5'-monophosphate-regulated phosphoprotein enriched in dopamine-innervated brain regions. I: Regional and cellular distribution in the rat brain. J Neurosci 4:84-98 (Pubitemid 14198290)
7. Hemmings HC Jr, Nairn AC, Bibb JA, Greengard P (1995) Signal transduction in the striatum: DARPP-32, a molecular integrator of multiple signaling pathways. In: Ariano MA, Surmeier DJ (eds) Molecular and cellular mechanisms of neostriatal function. Landes, Austin, pp 283-297
8. Greengard P, Allen PB, Nairn AC (1999) Beyond the dopamine receptor: the DARPP-32/protein phosphatase-1 cascade. Neuron 23:435-447 (Pubitemid 29359916)
9. Albert KA, Hemmings HC Jr, Adamo AIB, Potkin SG, Akbarian S, Sandman CA, Cotman CW, Bunney WE, Greengard P (2002) Evidence for decreased DARPP-32 in the prefrontal cortex of patients with schizophrenia. Arch Gen Psychiatry 59:705-712 (Pubitemid 34847943)
10. Ishikawa M, Mizukami K, Iwakiri M, Asada T (2007) Immunohistochemical and immunoblot analysis of dopamine and cyclic AMP-regulated phosphoprotein, relative molecular mass 32,000 (DARPP-32) in the prefrontal cortex of subjects with schizophrenia and bipolar disorder. Prog Neuropsychopharmacol Biol Psychiatry 31:1177-1181 (Pubitemid 47081302)
11. Baracskay KL, Haroutunian V, Meador-Woodruff JH (2006) Dopamine receptor signaling molecules are altered in elderly schizophrenic cortex. Synapse 60:271-279 (Pubitemid 44134347)
12. Li CH, Liao HM, Hung TW, Chen CH (2006) Mutation analysis of DARPP-32 as a candidate gene for schizophrenia. Schizophr Res 87:1-5
13. Hu JX, Yu L, Shi YY, Zhao XZ, Meng JW, He G, Xu YF, Feng GY, He L (2007) An association study between PPP1R1B gene and schizophrenia in the Chinese population. Prog Neuropsychopharmacol Biol Psychiatry 31:1303-1306 (Pubitemid 47081320)
14. Meyer-Lindenberg A, Straub RE, Lipska BK, Verchinski BA, Goldberg T, Callicott JH, Egan MF, Huffaker SS, Mattay VS, Kolachana B, Kleinman JE, Weinberger DR (2007) Genetic evidence implicating DARPP-32 in human frontostriatal structure, function, and cognition. J Clin Invest 117:672-682 (Pubitemid 46348525)
15. Clinton SM, Ibrahim HM, Frey KA, Davis KL, Haroutunian V, Meador-Woodruff JH (2005) Dopaminergic abnormalities in select thalamic nucleiin schizophrenia: involvement of the intracellular signal integrating proteins calcyon and spinophilin. Am J Psychiatry 162:1859-1871 (Pubitemid 41428615)
16. Fienberg AA, Greengard P (2000) The DARPP-32 knockout mouse. Brain Res Rev 31:313-319 (Pubitemid 30136186)
17. Grebb JA, Girault JA, Ehrlich M, Greengard P (1990) Chronic treatment of rats with SCH-23390 or raclopride does not affect the concentrations of DARPP-32 or its mRNA in dopamine-innervated brain regions. J Neurochem 55:204-207
18. Souza BR, Motta BS, Rosa DV, Torres KC, Castro AA, Comim CM, Sampaio AM, Lima FF, Jeromin A, Quevedo J, Romano-Silva MA (2008) DARPP-32 and NCS-1 expression is not altered in brains of rats treated with typical or atypical antipsychotics. Neurochem Res 33:533-538 (Pubitemid 351230456)
19. Rajkowska G, Goldman-Rakic PS (1995a) Cytoarchitectonic definition of prefrontal areas in the normal human cortex: I. Remapping of areas 9 and 46 using quantitative criteria. Cereb Cortex 5:307-322
20. Rajkowska G, Goldman-Rakic PS (1995) Cytoarchitectonic definition of prefrontal areas in the normal human cortex: II. Variability in locations of areas 9 and 46 and relationship to the Talairach Coordinate System. Cereb Cortex 5:323-337
21. Selemon LD, Rajkowska G, Goldman-Rakic PS (1995) Abnormally high neuronal density in the schizophrenic cortex. A morphometric analysis of prefrontal area 9 and occipital area 17. Arch Gen Psychiatry 52:805-818
22. Ito M, Depaz I, Wilce P, Suzuki T, Niwa S, Matsumoto I (2005) Expression of human neuronal protein 22, a novel cytoskeletonassociated protein, was decreased in the anterior cingulate cortex of schizophrenia. Neurosci Lett 378:125-130 (Pubitemid 40386857)
23. Iwazaki T, Shibata I, Niwa S, Matsumoto I (2004) Selective reduction of chromogranin A-like immunoreactivities in the prefrontal cortex of schizophrenic subjects: a post-mortem study. Neurosci Lett 367:293-297 (Pubitemid 39178599)
24. Tamagaki C, Sedvall GC, Jönsson EG, Okugawa G, Hall H, Pauli S, Agartz I (2005) Altered white matter/gray matter proportions in the striatum of patients with schizophrenia: a volumetric MRI study. Am J Psychiatry 162:2315-2321 (Pubitemid 41740210)
25. Lara DR, Gama CS, Belmonte-de-Abreu P, Portela LV, Gonçalves CA, Fonseca M, Hauck S, Souza DO (2001) Increased serum S100B protein in schizophrenia: a study in medication-free patients. J Psychiatr Res 35(6):347-350
26. Rothermundt M, Falkai P, Ponath G, Abel S, Bürkle H, Diedrich M, Hetzel G, Peters M, Siegmund A, Pedersen A, Maier W, Schramm J, Suslow T, Ohrmann P, Arolt V (2004) Glial cell dysfunction in schizophrenia indicated by increased S100B in the CSF. Mol Psychiatry 9:897-899 (Pubitemid 39381953)
27. Coyle JT, Schwarcz R (2000) Mind glue: implications of glial cell biology for psychiatry. Arch Gen Psychiatry 57:90-93 (Pubitemid 30035667)
28. Rajkowska G, Miguel-Hidalgo JJ, Makkos Z, Meltzer H, Overholser J, Stockmeier C (2002) Layer-specific reductions in GFAP-reactive astroglia in the dorsolateral prefrontal cortex in schizophrenia. Schizophr Res 57:127-138 (Pubitemid 35240014)
29. Webster MJ, O'Grady J, Kleinman JE, Weickert CS (2005) Glial fibrillary acidic protein mRNA levels in the cingulate cortex of individuals with depression, bipolar disorder and schizophrenia. Neuroscience 133:453-461 (Pubitemid 40726212)
30. Johnston-Wilson NL, Sims CD, Hofmann JP, Anderson L, Shore AD, Torrey EF, Yolken RH (2000) Disease-specific alterations in frontal cortex brain proteins in schizophrenia, bipolar disorder, and major depressive disorder. The Stanley Neuropathology Consortium. Mol Psychiatry 5:142-149 (Pubitemid 30229428)
31. Hakak Y, Walker JR, Li C, Wong WH, Davis KL, Buxbaum JD, Haroutunian V, Fienberg AA (2001) Genome-wide expression analysis reveals dysregulation of myelination-related genes in chronic schizophrenia. Proc Natl Acad Sci U S A 98:4746-4751 (Pubitemid 32295047)
32. Park SK, Miller R, Krane I, Vartanian T (2001) The erbB2 gene is required for the development of terminally differentiated spinal cord oligodendrocytes. J Cell Biol 154:1245-1258 (Pubitemid 34286201)
33. Fellin T, Sul JY, D'Ascenzo M, Takano H, Pascual O, Haydon PG (2006) Bidirectional astrocyte-neuron communication: the many roles of glutamate and ATP. Novartis Found Symp 276:208-217
34. D'Antoni S, Berretta A, Bonaccorso CM, Bruno V, Aronica E, Nicoletti F, Catania MV (2008) Metabotropic glutamate receptors in glial cells. Neurochem Res 33:2436-2443
35. Haydon PG (2001) Glia: listening and talking to the synapse. Nat Rev Neurosci 2:185-193 (Pubitemid 33673371)